Senior insider sale
Chief Executive Officer at LEGEND BIOTECH CORP — senior position signals high conviction
$778.2K
22.42K shares
What this filing means
HUANG YING plans to sell 22.42K shares of LEGEND BIOTECH CORP valued at approximately $778.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/24/2025ACC: 0001959173-25-004278
DirectorOfficer· Chief Executive Officer
Since Mar 2026
22.42K
Shares to sell
$778.2K
Approx. market value
11.81K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/20/2025
11.81KTotal acquired11.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/20/2025 | Restricted Stock Vesting Compensation | 11.81K | — |
| Total | 11.81K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
6.55K
Market value
$226.2K
5/1/2025
—Completed
Units to sell
4.06K
Market value
$143.4K
3/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
11.81K
Market value
$408.6K
6/24/2025
Total
Units
22.42K
Value
$778.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2025 | 6.55K | $226.2K | — | Completed |
3/25/2025 | 4.06K | $143.4K | — | Completed |
| Planned — Approximate Date | ||||
6/24/2025 | 11.81K | $408.6K | NASDAQ | Planned |
| Total | 22.42K | $778.2K | ||